BCIDP study plan
BCIDP · Give each week a clear focus.
8 weeks · About 7 hours per week
Microbiology, Pathophysiology, and Immunology of Infectious Diseases & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents
Map the weight of each domain against exam percentage and allocate remaining study hours accordingly
Explain the structure, resistance mechanisms, and virulence factors of the major bacterial pathogens by organism class
Describe key fungal, viral, and mycobacterial pathogen biology and how each shapes drug selection
Define pharmacodynamic indices (time above MIC, Cmax/MIC, AUC/MIC) and classify major antimicrobial classes as concentration- or time-dependent killers
Build a one-page reference table linking each major drug class to its PK/PD driver and target attainment threshold
Your checkpoint
A two-page organism-to-drug-class summary sheet plus a PK/PD driver table covering at least 12 antimicrobial classes
Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents & Microbiology, Pathophysiology, and Immunology of Infectious Diseases
Derive the pharmacokinetic parameters (Vd, clearance, half-life, bioavailability) that govern empiric dosing decisions
Compare absorption, distribution, and elimination differences among beta-lactams, glycopeptides, aminoglycosides, fluoroquinolones, and azoles
Explain host immune defenses and how immunocompromise alters expected drug response and prophylaxis choices
Predict how renal or hepatic impairment, obesity, and protein binding shift dosing for at least five agents
Work through 15 PK calculation problems (loading dose, maintenance dose, AUC estimation) without reference
Your checkpoint
Completed 15-item PK calculation worksheet with at least 90% accuracy and a written explanation for each missed item
Clinical Management of Infectious Diseases Syndromes & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents
Select empiric regimens for community-acquired pneumonia, urinary tract infection, and intra-abdominal infection using local resistance patterns
Justify de-escalation and definitive therapy choices based on culture and susceptibility results
Explain the pharmacology and spectrum of beta-lactam/beta-lactamase inhibitor combinations and compare their roles
Differentiate the clinical presentation and management of sepsis, endocarditis, and meningitis
Identify the PK/PD rationale for extended-infusion beta-lactams and when to recommend them
Your checkpoint
Three written syndrome-based case analyses (pneumonia, bacteremia/endocarditis, intra-abdominal) each with empiric, definitive, and de-escalation rationale
Antimicrobial Stewardship and Infection Prevention & Clinical Management of Infectious Diseases Syndromes
Design a stewardship intervention (prospective audit and feedback, preauthorization, or syndrome-specific pathway) and describe its metrics
Explain how to build and interpret an antibiogram and apply it to empiric therapy decisions
Describe core infection prevention practices including hand hygiene, isolation precautions, and device-related bundle elements
Apply Clostridioides difficile and multidrug-resistant organism prevention strategies to a hospital scenario
Outline the diagnostic workup for skin and soft tissue infection, osteomyelitis, and prosthetic joint infection
Your checkpoint
A one-page stewardship business case with a proposed intervention, target metric, and 90-day evaluation plan
Clinical Management of Infectious Diseases Syndromes & Diagnostic Testing, Susceptibility Interpretation, and Therapeutic Drug Monitoring
Manage fungal infections (candidemia, invasive aspergillosis, cryptococcal disease) with appropriate antifungal selection and monitoring
Select and sequence antiretroviral and opportunistic infection therapy for a patient with advanced HIV
Interpret minimum inhibitory concentration, breakpoints, and susceptibility categories for common organisms
Explain when and how to order therapeutic drug monitoring for vancomycin, aminoglycosides, and voriconazole
Differentiate colonization from true infection when interpreting respiratory and wound cultures
Your checkpoint
A completed susceptibility interpretation exercise (10 isolates) with a written TDM plan for two of the agents involved
Special Populations and Antimicrobial Dosing Considerations & Patient Safety, Adverse Effects, Drug Interactions, and Regulatory/Professional Practice
Adjust antimicrobial dosing for patients on renal replacement therapy, extracorporeal membrane oxygenation, and in critical illness with altered volume of distribution
Develop dosing and monitoring plans for pregnancy, neonates, and older adults with polypharmacy
Identify clinically significant antimicrobial drug interactions and describe the monitoring required for each
Recognize and manage serious adverse effects including nephrotoxicity, hepatotoxicity, QT prolongation, and severe hypersensitivity
Describe regulatory and professional practice expectations relevant to antimicrobial use and stewardship accountability
Your checkpoint
A special-population dosing reference card covering at least eight agents across renal replacement, pregnancy, and pediatric categories
Microbiology, Pathophysiology, and Immunology of Infectious Diseases & Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents & Clinical Management of Infectious Diseases Syndromes
Synthesize microbiology, pharmacology, and clinical management into integrated management plans for unfamiliar organisms
Explain resistance mechanisms (ESBL, carbapenemase, MRSA, VRE) and match each to appropriate therapeutic alternatives
Review and correct weak areas identified in prior weeks using a personal error log
Complete a timed 60-question mixed-domain practice set under exam conditions
Analyze every missed practice question and classify the error as knowledge, interpretation, or reasoning
Your checkpoint
A categorized error log from the 60-question practice set with a remediation action for each error category
Antimicrobial Stewardship and Infection Prevention & Clinical Management of Infectious Diseases Syndromes & Special Populations and Antimicrobial Dosing Considerations & Diagnostic Testing, Susceptibility Interpretation, and Therapeutic Drug Monitoring & Patient Safety, Adverse Effects, Drug Interactions, and Regulatory/Professional Practice
Rehearse rapid decision-making across all domains with two additional timed practice sets
Recite from memory the top 25 high-yield facts spanning PK/PD, stewardship metrics, and syndrome-specific therapy
Review the error log and confirm closure of every prior knowledge gap
Practice explaining stewardship and safety rationale aloud to simulate case-based reasoning
Finalize a one-page pre-exam summary sheet limited to the highest-yield content
Your checkpoint
A one-page high-yield summary sheet plus documented closure of at least 90% of error-log items
Milestones
Week 2: Score at least 90% on the PK calculation worksheet and correctly match all 12 antimicrobial classes to their PK/PD driver without notes
Week 4: Produce a complete stewardship intervention proposal with defined metrics and correctly interpret an antibiogram to justify three empiric regimen choices
Week 6: Demonstrate correct dosing adjustments for at least six of eight agents on the special-population card and identify all major drug interactions in a polypharmacy scenario
Week 7: Score at least 70% on the timed 60-question mixed-domain practice set and show a fully categorized error log
Week 8: Score at least 80% on the final timed practice set and document closure of at least 90% of error-log items